Annex 4 Guidelines on viral inactivation and removal ...
EBV Epstein–Barr virus. An enveloped, double-stranded DNA virus, typically cell-associated. EMCV Encephalomyocarditis virus. A non-enveloped, single-stranded, RNA virus. Factor IX Blood coagulation factor IX, missing in patients with haemophilia B. Factor VIII Blood coagulation factor VIII, missing in patients with haemophilia A. Also called
Download Annex 4 Guidelines on viral inactivation and removal ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
health
health.gov.zaEBV Epstein Barr virus EML essential medicines list EPI Expanded Programme on Immunisation EU European Union GLOBOCAN Global Burden of Cancer Study HIC high income countries HIV human immunodeficiency virus HBV hepatitis B virus …
DIAGNOSTICO DE LA INFECCION POR VIRUS DE EPSTEIN BARR
www.aepap.orgEs un marcador de haber padecido infección por Epstein Barr. -Ig G anti EBNA- antígeno nuclear de Epstein Barr: Aparece entre las 6-12 semanas del inicio de los síntomas y generalmente persiste de por vida. Si aparece en una serología inicial indica que los síntomas no se pueden atribuir a una infección aguda por VEB.
Person with the infection Those in contact with the ...
www.health.qld.gov.au(mononucleosis, Epstein-Barr virus) NOT EXCLUDED NOT EXCLUDED *German measles (rubella)˜ EXCLUDE for 4 da ysa˚er the on et o rash˜ or unti lfu rc v ed, whichever is longer. Pregnant women should consult with their doctor. NOT EXCLUDED preg na t women should consult with their doctor. *Haemophilus influenzae type b (Hib)